Multiple oral medicinal product form unit dosage in tablet process for preparation of tablet formulation for inhibition of gastric acid secretion in mammals and man for the treatment of gastrointestinal inflammatory diseases in maniferous and in man and transverse pressure ampoule embalming

摘要

A new pharmaceutical multiple unit tableted dosage form containing as active substance an acid labile H+K+-ATPase inhibitor or an alkaline salt thereof or one of its single enantiomers or an alkaline salt thereof, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.